Prevention of anaemia by early intervention with once weekly epoetin alfa during chemotherapy

European Journal of Cancer

Volumn 44, Issue 6, 2008, Pages 819-829

  Schouwink, J H ^a   Codrington, H ^b   Sleeboom, H P ^b   Kerkhofs, L G M ^c   Wormhoudt, L W ^d  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b HAGA HOSPITAL   (Netherlands)

^c Ziekenhuis Walcheren   (Netherlands)

^d Janssen Cilag BV Netherlands   (Netherlands)

Author keywords

Anaemia; Blood transfusion; Erythropoietin; Haemoglobin

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ABDOMINAL PAIN; ADULT; ALOPECIA; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BONE PAIN; BRAIN INFARCTION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CLINICAL TRIAL; COLLAPSE; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG TOLERABILITY; DYSPNEA; FATIGUE; FEMALE; FEVER; HEART ARREST; HEART FAILURE; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOPENIA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROPATHY; OVERALL SURVIVAL; PANCYTOPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHOCK; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; THROMBOCYTOPENIA; THROMBOPHLEBITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VASCULAR DISEASE; VASCULITIS; VOMITING;

ADOLESCENT; ADULT; AGED; ANEMIA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD TRANSFUSION; DRUG ADMINISTRATION SCHEDULE; EPOETIN ALFA; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 41949138922     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.02.017     Document Type: Article

References (28)

1. Groopman J.E., and Itri L.M. Chemotherapy-induced anaemia in adults: incidence and treatment. J Natl Cancer Inst 91 (1999) 1616-1634
2. Ludwig H., Van Belle S., Barrett-Lee P., et al. The European Cancer Anaemia Survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 40 (2004) 2293-2306
3. Bokemeyer C., Aapro M.S., Courdi A., et al. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update. Eur J Cancer 43 (2007) 258-270
4. Witzig T.E., Silberstein P.T., Loprinzi C.L., et al. Phase III randomized, double-blind study of epoetin alfa compared with placebo in anaemic patients receiving chemotherapy. J Clin Oncol 23 (2005) 2606-2617
5. Cella D., Zagari M.J., Vandoros C., Gagnon D.D., Hurtz H.J., and Nortier J.W.R. Epoetin alfa treatment results in clinically significant improvements in quality of life in anaemic cancer patients when referenced to the general population. J Clin Oncol 21 (2003) 366-373
6. Gabrilove J.L., Cleeland C.S., Livingston R.B., Sarokhan B., Winer E., and Einhorn L.H. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in haemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 19 (2001) 2875-2882
7. Littlewood T.J., Bajetta E., Nortier J.W.R., Vercammen E., Rapoport B., and for the Epoetin Alfa Study Group. Effects of epoetin alfa on haematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 19 (2001) 2865-2874
8. Glaspy J., Bukowski R., Steinberg D., et al. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 15 (1997) 1218-1234
9. Fallowfield L., Gagnon D., Zagari M., et al. Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapy. Br J Cancer 87 (2002) 1341-1353
10. Dammacco F., Castoldi G., and Rödjer S. Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma. Br J Haematol 113 (2001) 172-179
11. Littlewood T.J., Nortier J., Rapoport B., et al. Epoetin alfa corrects anaemia and improves quality of life in patients with haematologic malignancies receiving non-platinum chemotherapy. Hematol Oncol 21 (2003) 169-180
12. Demetri G.D., Kris M., Wade J., Degos L., Cella D., and for the Procrit Study Group. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. J Clin Oncol 16 (1998) 3412-3425
13. Crawford J., Cella D., Cleeland C.S., et al. Relationship between changes in haemoglobin level and quality of life during chemotherapy in anaemic cancer patients receiving epoetin alfa therapy. Cancer 95 (2002) 888-895
14. Rizzo J.D., Somerfield M.R., Hagerty K.L., et al. Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update. J Clin Oncol 26 (2008) 132-149
15. Hudis C.A., Vogel C.L., Gralow J.R., Williams D., and and the Procrit Study Group. Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life. Clin Breast Cancer 6 (2005) 132-142
16. Wilkinson P.M., Antonopoulos M., Lahousen M., Lind M., Kosmidis P., and for the EPO-INT-45 Study Group. Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial. Br J Cancer 94 (2006) 947-954
17. Pronzato P., Cortesi E., van der Rijt C., et al. Early intervention with epoetin alfa in breast cancer (BC) patients (pts) undergoing chemotherapy (CT): results of a randomized, multicenter, phase IIIb study (EPO-INT-47 Study Group). Ann Oncol 13 Suppl. 5 (2002) 168 [abstract 6200]
18. Crawford J., Robert F., Perry M., Belani C.P., Sarokhan B., and for the Anaemia Prevention in NSCLC Study Group. Epoetin alfa 40,000 U once weekly maintains haemoglobin in advanced non-small-cell lung cancer patients receiving first-line chemotherapy. Proc Am Soc Clin Oncol 22 (2003) 628 [abstract 2527]
19. Chang J., Couture F., Young S., McWatters K.L., and Lau C.Y. Weekly epoetin alfa maintains haemoglobin, improves quality of life, and reduces transfusion in breast cancer patients receiving chemotherapy. J Clin Oncol 23 (2005) 2597-2605
20. Milroy R., Scagliotti G., van den Berg P.M., et al. Early intervention with Epoetin alfa maintains haemoglobin (Hb) in advanced non-small-cell lung cancer (NSCLC) patients. Lung Cancer 41 (2003) S74 [abstract O-253]
21. Savonije J.H., van Groeningen C.J., van Bochove A., et al. Effects of early intervention with epoetin alfa on transfusion requirement, haemoglobin level and survival during platinum-based chemotherapy: results of a multicenter randomised controlled trial. Eur J Cancer 41 (2005) 1560-1569
22. Richart J.M., Petruska P.J., Klebert K.S., et al. A Phase III trial of Epoetin-alfa: early vs late administration in patients treated with chemotherapy. Blood 100 (2002) 175b [abstract 4199]
23. Straus D.J., Testa M.A., Sarokhan B.J., et al. Quality-of-life and health benefits of early treatment of mild anaemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for haematologic malignancies. Cancer 107 (2006) 1909-1917
24. Crawford J., Robert F., Perry M., Belani C., Williams D., and Anemia Prevention in NSCLC Group. A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy. J Thorac Oncol 2 (2007) 210-220
25. Lyman G.H., and Glaspy J. Are there clinical benefits with early erythropoietic intervention for chemotherapy-induced anemia? A systematic review. Cancer 106 (2006) 223-233
26. Bohlius J., Wilson J., Seidenfeld J., et al. Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 98 (2006) 708-714
27. Rizzo J.D., Lichtin A.E., Woolf S.H., et al. Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 20 (2002) 4083-4107
28. Charu V., Saidman B., Ben-Jacob A., et al. A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced anemia. Oncologist 12 (2007) 1253-1263